Literature DB >> 21038489

CADASIL and migraine: A narrative review.

Michael K Liem1, Saskia A J Lesnik Oberstein, Jeroen van der Grond, Michel D Ferrari, Joost Haan.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is caused by mutations in the NOTCH3 gene and is clinically characterized by recurrent stroke, cognitive decline, psychiatric disturbances and migraine. The prevalence of migraine in CADASIL is slightly higher than in the general population, and the proportion of migraine with aura is much higher. The pathophysiological mechanism that leads to increased aura prevalence in CADASIL is unknown. Possible mechanisms of the excess of migraine with aura are an increased susceptibility to cortical spreading depression (CSD) or a different expression of CSD. It is also possible that the brainstem migraine area is involved in CADASIL. Last, it is possible that the NOTCH3 mutation acts as a migraine aura susceptibility gene by itself. In this narrative review we summarize the literature about migraine in CADASIL, with a special focus on what CADASIL might teach us about the pathophysiology of migraine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21038489     DOI: 10.1177/0333102410370870

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  13 in total

Review 1.  Migraine and small vessel diseases.

Authors:  E Agostoni; A Rigamonti
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 2.  Recognizing CADASIL: a Secondary Cause of Migraine with Aura.

Authors:  John Glenn Burkett; Carrie Dougherty
Journal:  Curr Pain Headache Rep       Date:  2017-04

3.  Migraine genetics: current findings and future lines of research.

Authors:  A M Persico; M Verdecchia; V Pinzone; V Guidetti
Journal:  Neurogenetics       Date:  2014-12-14       Impact factor: 2.660

4.  Elderly CADASIL patients with intact neurological status.

Authors:  Ruiting Zhang; Elisa Ouin; Lina Grosset; Karine Ighilkrim; Jessica Lebenberg; Stéphanie Guey; Véronique François; Elisabeth Tournier-Lasserve; Eric Jouvent; Hugues Chabriat
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

5.  Phenotypic characterization of CADASIL patients with the Arg332Cys mutation in the NOTCH3.

Authors:  Chen-Si Li; Tian-Wei Wang; Jie Wang; Shuai-Hong Li; Na Li; Xiao-Shuang Wang; Le Fang
Journal:  Ann Transl Med       Date:  2020-01

Review 6.  Treatment of migraine in patients with CADASIL: A systematic review and meta-analysis.

Authors:  Patrick A Glover; Eric D Goldstein; Mohammed K Badi; Tara J Brigham; Elizabeth R Lesser; Thomas G Brott; James F Meschia
Journal:  Neurol Clin Pract       Date:  2020-12

7.  Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience.

Authors:  Ida Donnini; Serena Nannucci; Raffaella Valenti; Francesca Pescini; Silvia Bianchi; Domenico Inzitari; Leonardo Pantoni
Journal:  J Headache Pain       Date:  2012-02-25       Impact factor: 7.277

8.  Grey matter volume alterations in CADASIL: a voxel-based morphometry study.

Authors:  Maria Camilla Rossi Espagnet; Andrea Romano; Filippo Carducci; Luigi Fausto Calabria; Martina Fiorillo; Francesco Orzi; Alessandro Bozzao
Journal:  J Headache Pain       Date:  2012-02-03       Impact factor: 7.277

9.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

10.  CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships.

Authors:  Rhea Yan Ying Tan; Hugh Stephen Markus
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.